148 related articles for article (PubMed ID: 11545423)
1. Ocular complications of paediatric patients with nephrotic syndrome.
Ng JS; Wong W; Law RW; Hui J; Wong EN; Lam DS
Clin Exp Ophthalmol; 2001 Aug; 29(4):239-43. PubMed ID: 11545423
[TBL] [Abstract][Full Text] [Related]
2. Ocular findings in Japanese children with nephrotic syndrome receiving prolonged corticosteroid therapy.
Hayasaka Y; Hayasaka S; Matsukura H
Ophthalmologica; 2006; 220(3):181-5. PubMed ID: 16679793
[TBL] [Abstract][Full Text] [Related]
3. Ocular complications in children with nephrotic syndrome on long term oral steroids.
Gaur S; Joseph M; Nityanandam S; Subramanian S; Koshy AS; Vasudevan A; Phadke KD; Iyengar A
Indian J Pediatr; 2014 Jul; 81(7):680-3. PubMed ID: 24557606
[TBL] [Abstract][Full Text] [Related]
4. Steroid induced ocular complications in idiopathic nephrotic syndrome: a cross sectional single center study.
Zulfiqar Z; Lanewala F; Khatri S; Bajeer I; Aziz M; Hashmi S
J Pak Med Assoc; 2024 Feb; 74(2):315-319. PubMed ID: 38419233
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid-induced cataracts in idiopathic nephrotic syndrome.
Brocklebank JT; Harcourt RB; Meadow SR
Arch Dis Child; 1982 Jan; 57(1):30-4. PubMed ID: 7065690
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics of glucocorticoid-induced eye adverse reactions in children with primary nephrotic syndrome].
Zhao Y; Su BG; Xiao HJ; Zhang HW; Liu XY; Wang F; Ding J
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 49(5):794-797. PubMed ID: 29045958
[TBL] [Abstract][Full Text] [Related]
7. Incidence and predictive risk factors for ophthalmological complications in children with nephrotic syndrome receiving long-term oral corticosteroids: a cohort study.
Hariharan R; Krishnamurthy S; Kaliaperumal S; Karunakar P; Deepthi B
Paediatr Int Child Health; 2021 Aug; 41(3):199-205. PubMed ID: 34711131
[TBL] [Abstract][Full Text] [Related]
8. Early and frequent development of ocular hypertension in children with nephrotic syndrome.
Kawaguchi E; Ishikura K; Hamada R; Nagaoka Y; Morikawa Y; Sakai T; Hamasaki Y; Hataya H; Noda E; Miura M; Ando T; Honda M
Pediatr Nephrol; 2014 Nov; 29(11):2165-71. PubMed ID: 24859790
[TBL] [Abstract][Full Text] [Related]
9. Reversibility of corticosteroid-associated cataracts in children with the nephrotic syndrome.
Forman AR; Loreto JA; Tina LU
Am J Ophthalmol; 1977 Jul; 84(1):75-8. PubMed ID: 900221
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Ocular Steroid Hypertensive Response in Children.
Kaur S; Dhiman I; Kaushik S; Raj S; Pandav SS
J Glaucoma; 2016 Apr; 25(4):343-7. PubMed ID: 25651206
[TBL] [Abstract][Full Text] [Related]
11. Posterior subcapsular cataract in nephrotic children receiving steroid therapy.
Kobayashi Y; Akaishi K; Nishio T; Kobayashi Y; Kimura Y
Am J Dis Child; 1974 Nov; 128(5):671-3. PubMed ID: 4420227
[No Abstract] [Full Text] [Related]
12. Influence of cyclosporin on steroid-induced cataracts after renal transplantation.
Nakamura T; Sasaki H; Nagai K; Fujisawa K; Sasaki K; Suzuki K; Tsugawa R
Jpn J Ophthalmol; 2003; 47(3):254-9. PubMed ID: 12782160
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract.
Gillies MC; Kuzniarz M; Craig J; Ball M; Luo W; Simpson JM
Ophthalmology; 2005 Jan; 112(1):139-43. PubMed ID: 15629834
[TBL] [Abstract][Full Text] [Related]
14. Ocular manifestations of Takayasu arteritis: a cross-sectional study.
Peter J; David S; Danda D; Peter JV; Horo S; Joseph G
Retina; 2011 Jun; 31(6):1170-8. PubMed ID: 21317836
[TBL] [Abstract][Full Text] [Related]
15. Follow-up of linear growth of body height in children with nephrotic syndrome.
Hung YT; Yang LY
J Microbiol Immunol Infect; 2006 Oct; 39(5):422-5. PubMed ID: 17066206
[TBL] [Abstract][Full Text] [Related]
16. Relationship of steroid dose to degree of posterior subcapsular cataracts in nephrotic syndrome.
Limaye SR; Pillai S; Tina LU
Ann Ophthalmol; 1988 Jun; 20(6):225-7. PubMed ID: 3408090
[TBL] [Abstract][Full Text] [Related]
17. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
Singh DN; Krishnamurthy S; Kamalanathan SK; Harichandrakumar KT; Sivamurukan P
Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
[TBL] [Abstract][Full Text] [Related]
18. Ocular implications of long-term prednisone therapy in children.
Kaye LD; Kalenak JW; Price RL; Cunningham R
J Pediatr Ophthalmol Strabismus; 1993; 30(3):142-4. PubMed ID: 8350220
[TBL] [Abstract][Full Text] [Related]
19. Ocular manifestations of HIV infection.
Jabs DA
Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
[TBL] [Abstract][Full Text] [Related]
20. [Ocular complications after renal transplantation].
Shimmyo A; Miyazaki S; Onoe S; Nojima M; Ihara H; Ikoma F
Nippon Ganka Gakkai Zasshi; 1997 Mar; 101(3):220-6. PubMed ID: 9086740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
